At present,the incidence rate of endometrial cancer(EC)in China is increasing year by year and showing a younger trend.Early EC has a good prognosis after standardized treatment,so EC screening is increasingly valued.Pathological examination is the"gold standard"for diagnosing endometrial lesions,but its promotion in clinical screening is limited due to the invasiveness of sampling techniques.More and more stud-ies are exploring the value of novel biomarkers in EC screening using minimally invasive sampling techniques,gene methylation detection,and other methods.The article reviews EC screening methods and research pro-gress.
维普
万方数据